School of Pharmacy

Search results

• CCDC 722592: Experimental Crystal Structure Determination

  Chang, S. (Contributor), Chou, B. (Contributor), Yang, L. (Contributor), Hsu, F. (Contributor), Lin, W. (Contributor), Ho, Y. (Contributor) & Lin, S. (Contributor), Unknown Publisher, Jan 1 2010

  DOI: 10.5517/ccs7xfb, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/ccs7xfb&sid=DataCite

  Dataset

• MOESM1 of Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study

  Lee, M. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Wang, J. (Contributor) & Chen, S. (Contributor), Unknown Publisher, Jan 1 2019

  DOI: 10.6084/m9.figshare.10264502.v1, https://springernature.figshare.com/articles/MOESM1_of_Impact_of_metformin_use_among_tuberculosis_close_contacts_with_diabetes_mellitus_in_a_nationwide_cohort_study/10264502/1

  Dataset

• CCDC 807651: Experimental Crystal Structure Determination

  Yang, L. (Contributor), Chang, S. (Contributor), Lin, W. (Contributor), Chou, B. (Contributor), Wang, L. (Contributor), Liu, P. (Contributor) & Lin, S. (Contributor), Unknown Publisher, Jan 1 2012

  DOI: 10.5517/ccw3f8n, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/ccw3f8n&sid=DataCite

  Dataset

• CCDC 807649: Experimental Crystal Structure Determination

  Yang, L. (Contributor), Chang, S. (Contributor), Lin, W. (Contributor), Chou, B. (Contributor), Wang, L. (Contributor), Liu, P. (Contributor) & Lin, S. (Contributor), Unknown Publisher, Jan 1 2012

  DOI: 10.5517/ccw3f6l, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/ccw3f6l&sid=DataCite

  Dataset

• Patient preferences for diabetes-related complications in Taiwan

  Lin, Y. (Contributor), Wang, C. (Contributor), Cheng, S. (Contributor) & Ko, Y. (Contributor), Unknown Publisher, Jan 2 2019

  DOI: 10.6084/m9.figshare.6194663.v1, https://tandf.figshare.com/articles/Patient_preferences_for_diabetes-related_complications_in_Taiwan/6194663/1

  Dataset

• CCDC 898186: Experimental Crystal Structure Determination

  Chang, S. (Contributor), Yang, L. (Contributor), Huang, T. (Contributor), Chen, C. (Contributor), Sheu, S. (Contributor), Liu, P. (Contributor) & Lin, S. (Contributor), Unknown Publisher, Jan 1 2016

  DOI: 10.5517/ccz4mrg, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/ccz4mrg&sid=DataCite

  Dataset

• CCDC 660699: Experimental Crystal Structure Determination

  Chou, B. (Contributor), Yang, L. (Contributor), Chang, S. (Contributor), Hsu, F. (Contributor), Lo, C. (Contributor), Liaw, J. (Contributor), Liu, P. (Contributor) & Lin, S. (Contributor), Unknown Publisher, Jan 1 2009

  DOI: 10.5517/ccq5hw7, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/ccq5hw7&sid=DataCite

  Dataset

• CCDC 660698: Experimental Crystal Structure Determination

  Chou, B. (Contributor), Yang, L. (Contributor), Chang, S. (Contributor), Hsu, F. (Contributor), Lo, C. (Contributor), Liaw, J. (Contributor), Liu, P. (Contributor) & Lin, S. (Contributor), Unknown Publisher, Jan 1 2009

  DOI: 10.5517/ccq5hv6, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/ccq5hv6&sid=DataCite

  Dataset

• Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer

  Chang, C. (Contributor), Hsieh, C. (Contributor), Chen, L. (Contributor), Su, C. (Contributor), Liu, D. (Contributor), Jhan, H. (Contributor), Ho, H. (Contributor) & Sheu, M. (Contributor), Unknown Publisher, Jan 1 2018

  DOI: 10.6084/m9.figshare.5908795.v1, https://tandf.figshare.com/articles/Novel_application_of_pluronic_lecithin_organogels_PLOs_for_local_delivery_of_synergistic_combination_of_docetaxel_and_cisplatin_to_improve_therapeutic_efficacy_against_ovarian_cancer/5908795/1

  Dataset

• Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

  Chao, M. (Contributor), Chang, L. (Contributor), Tu, H. (Contributor), Chang, C. (Contributor), Lai, M. (Contributor), Chen, Y. (Contributor), Liou, J. (Contributor), Teng, C. (Contributor) & Pan, S. (Contributor), Unknown Publisher, May 29 2019

  DOI: 10.6084/m9.figshare.8202902.v1, https://springernature.figshare.com/articles/Additional_file_5_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202902/1

  Dataset

• Inhaled gold nanoparticles cause cerebral edema and upregulate endothelial aquaporin 1 expression, involving caveolin 1 dependent repression of extracellular regulated protein kinase activity

  Chen, C. (Contributor), Liao, P. (Contributor), Tsai, C. (Contributor), Chan, Y. (Contributor), Cheng, Y. (Contributor), Hwang, L. (Contributor), Lin, K. (Contributor), Yen, T. (Contributor) & Li, C. (Contributor), Unknown Publisher, Oct 16 2019

  DOI: 10.6084/m9.figshare.c.4701761.v1, https://doi.org/10.6084%2Fm9.figshare.c.4701761.v1

  Dataset

• The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells

  Tu, H. (Contributor), Lin, Y. (Contributor), Chao, M. (Contributor), Sung, T. (Contributor), Wu, Y. (Contributor), Chen, Y. (Contributor), Lin, M. (Contributor), Liou, J. (Contributor), Pan, S. (Contributor) & Yang, C. (Contributor), Unknown Publisher, Dec 29 2018

  DOI: 10.6084/m9.figshare.c.4350887.v1, https://springernature.figshare.com/collections/The_anticancer_effects_of_MPT0G211_a_novel_HDAC6_inhibitor_combined_with_chemotherapeutic_agents_in_human_acute_leukemia_cells/4350887/1

  Dataset

• Additional file 3: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

  Chao, M. (Contributor), Chang, L. (Contributor), Tu, H. (Contributor), Chang, C. (Contributor), Lai, M. (Contributor), Chen, Y. (Contributor), Liou, J. (Contributor), Teng, C. (Contributor) & Pan, S. (Contributor), Unknown Publisher, May 29 2019

  DOI: 10.6084/m9.figshare.8202890.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202890/1

  Dataset

• Structure-guided design of anti-cancer ribonucleotide reductase inhibitors

  Misko, T. A. (Contributor), Liu, Y. (Contributor), Harris, M. E. (Contributor), Oleinick, N. L. (Contributor), Pink, J. (Contributor), Lee, H. (Contributor) & Dealwis, C. G. (Contributor), Unknown Publisher, Jan 1 2019

  DOI: 10.6084/m9.figshare.7553114.v1, https://tandf.figshare.com/articles/Structure-guided_design_of_anti-cancer_ribonucleotide_reductase_inhibitors/7553114/1

  Dataset

• Additional file 4: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

  Chao, M. (Contributor), Chang, L. (Contributor), Tu, H. (Contributor), Chang, C. (Contributor), Lai, M. (Contributor), Chen, Y. (Contributor), Liou, J. (Contributor), Teng, C. (Contributor) & Pan, S. (Contributor), Unknown Publisher, May 29 2019

  DOI: 10.6084/m9.figshare.8202896.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202896/1

  Dataset

• Additional file 1: of The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells

  Tu, H. (Contributor), Lin, Y. (Contributor), Chao, M. (Contributor), Sung, T. (Contributor), Wu, Y. (Contributor), Chen, Y. (Contributor), Lin, M. (Contributor), Liou, J. (Contributor), Pan, S. (Contributor) & Yang, C. (Contributor), Unknown Publisher, Dec 29 2018

  DOI: 10.6084/m9.figshare.7531874.v1, https://springernature.figshare.com/articles/Additional_file_1_of_The_anticancer_effects_of_MPT0G211_a_novel_HDAC6_inhibitor_combined_with_chemotherapeutic_agents_in_human_acute_leukemia_cells/7531874/1

  Dataset

• Additional file 1: of V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients

  Wong, H. (Contributor), Chang, C. (Contributor), Kao, C. (Contributor), Hsu, Y. (Contributor), Liu, X. (Contributor), Chang, W. (Contributor), Wu, M. (Contributor) & Chang, W. (Contributor), Unknown Publisher, Jul 11 2017

  DOI: 10.6084/m9.figshare.c.3824278_d1.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_V-J_combinations_of_T-cell_receptor_predict_responses_to_erythropoietin_in_end-stage_renal_disease_patients/5197441/1

  Dataset

• MOESM9 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning

  Wong, H. (Contributor), Lin, Y. (Contributor), Lu, H. (Contributor), Liao, W. (Contributor), Chen, C. (Contributor), Wu, J. (Contributor), Chang, W. (Contributor) & Tsai, F. (Contributor), Unknown Publisher, Jan 1 2019

  DOI: 10.6084/m9.figshare.10270469.v1, https://springernature.figshare.com/articles/MOESM9_of_Genomic_interrogation_of_familial_short_stature_contributes_to_the_discovery_of_the_pathophysiological_mechanisms_and_pharmaceutical_drug_repositioning/10270469/1

  Dataset

• Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors

  Su, C. (Contributor), Chen, M. (Contributor), Chen, L. (Contributor), Ho, Y. (Contributor), Ho, H. (Contributor), Lin, S. (Contributor), Chuang, K. (Contributor) & Sheu, M. (Contributor), Unknown Publisher, May 2 2018

  DOI: 10.6084/m9.figshare.6213620.v1, https://tandf.figshare.com/articles/Bispecific_antibodies_anti-mPEG_anti-HER2_for_active_tumor_targeting_of_docetaxel_DTX_-loaded_mPEGylated_nanocarriers_to_enhance_the_chemotherapeutic_efficacy_of_HER2-overexpressing_tumors/6213620/1

  Dataset

• Additional file 8: of V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients

  Wong, H. (Contributor), Chang, C. (Contributor), Kao, C. (Contributor), Hsu, Y. (Contributor), Liu, X. (Contributor), Chang, W. (Contributor), Wu, M. (Contributor) & Chang, W. (Contributor), Unknown Publisher, Jul 11 2017

  DOI: 10.6084/m9.figshare.c.3824278_d8.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_8_of_V-J_combinations_of_T-cell_receptor_predict_responses_to_erythropoietin_in_end-stage_renal_disease_patients/5197597/1

  Dataset

• The association between BDNF Val66Met polymorphism and emotional symptoms after mild traumatic brain injury

  Wang, Y. (Contributor), Chen, K. (Contributor), Kuo, L. (Contributor), Wang, W. (Contributor), Hsu, Y. (Contributor), Wong, H. (Contributor), Lin, C. (Contributor), Liao, K. (Contributor), Zhang, Y. (Contributor), Chiang, Y. (Contributor) & Chang, W. (Contributor), Unknown Publisher, Jan 22 2018

  DOI: 10.6084/m9.figshare.c.3983745.v1, https://figshare.com/collections/The_association_between_BDNF_Val66Met_polymorphism_and_emotional_symptoms_after_mild_traumatic_brain_injury/3983745/1

  Dataset

• MOESM4 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning

  Wong, H. (Contributor), Lin, Y. (Contributor), Lu, H. (Contributor), Liao, W. (Contributor), Chen, C. (Contributor), Wu, J. (Contributor), Chang, W. (Contributor) & Tsai, F. (Contributor), Unknown Publisher, Jan 1 2019

  DOI: 10.6084/m9.figshare.10270445.v1, https://springernature.figshare.com/articles/MOESM4_of_Genomic_interrogation_of_familial_short_stature_contributes_to_the_discovery_of_the_pathophysiological_mechanisms_and_pharmaceutical_drug_repositioning/10270445/1

  Dataset

• Association of endothelin genetic variants and hospitalized infection complications in end-stage renal disease (ESRD) patients

  Kao, C. (Contributor), Cheng, S. (Contributor), Wang, Y. (Contributor), Chien, S. (Contributor), Hsu, Y. (Contributor), Wu, M. (Contributor), Lu, H. (Contributor), Nam, S. (Contributor), Sun, T. (Contributor), Wu, M. (Contributor) & Chang, W. (Contributor), Unknown Publisher, Jun 5 2019

  DOI: 10.6084/m9.figshare.c.4531100.v1, https://doi.org/10.6084%2Fm9.figshare.c.4531100.v1

  Dataset

• MOESM7 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning

  Wong, H. (Contributor), Lin, Y. (Contributor), Lu, H. (Contributor), Liao, W. (Contributor), Chen, C. (Contributor), Wu, J. (Contributor), Chang, W. (Contributor) & Tsai, F. (Contributor), Unknown Publisher, Jan 1 2019

  DOI: 10.6084/m9.figshare.10270460.v1, https://springernature.figshare.com/articles/MOESM7_of_Genomic_interrogation_of_familial_short_stature_contributes_to_the_discovery_of_the_pathophysiological_mechanisms_and_pharmaceutical_drug_repositioning/10270460/1

  Dataset

• MOESM5 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning

  Wong, H. (Contributor), Lin, Y. (Contributor), Lu, H. (Contributor), Liao, W. (Contributor), Chen, C. (Contributor), Wu, J. (Contributor), Chang, W. (Contributor) & Tsai, F. (Contributor), Unknown Publisher, Jan 1 2019

  DOI: 10.6084/m9.figshare.10270451.v1, https://springernature.figshare.com/articles/MOESM5_of_Genomic_interrogation_of_familial_short_stature_contributes_to_the_discovery_of_the_pathophysiological_mechanisms_and_pharmaceutical_drug_repositioning/10270451/1

  Dataset